Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review

Since 2003, only two chemotherapeutic agents, evaluated in phase III trials, have been approved by the US Food and Drug Administration for treatment of newly diagnosed high-grade glioma (HGG): Gliadel wafers (intracranially implanted local chemotherapy) and temozolomide (TMZ) (systemic chemotherapy)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashby, Lynn S., Smith, Kris A., Stea, Baldassarre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997737/
https://www.ncbi.nlm.nih.gov/pubmed/27557526
http://dx.doi.org/10.1186/s12957-016-0975-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997737/
https://www.ncbi.nlm.nih.gov/pubmed/27557526
http://dx.doi.org/10.1186/s12957-016-0975-5

Ejemplares similares